LIPASA
Mexico·Clase I·III. DIAGNOSTIC AGENTS·DIAGMEX, S.A. DE C.V.·Registered October 08, 2020REACTIVOPARALADETERMINACIÓNINVITRODE LIPASA EN SUERO Y PLASMA POR ELMÉTODO COLORIMETRICO
REAGENT FOR THE DETERMINATION INVITRODE LIPASE IN SERUM AND PLASMA BY THE COLORIMETRIC METHOD
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVOPARALADETERMINACIÓNDE LIPASA
- Trade Name (English)
- REAGENT for the determination of LIPASE
- Analysis ID
- 1370R2020 SSA
- Registration Date
- October 08, 2020
- Name (Spanish)
- DIAGMEX, S.A. DE C.V.
- Name (English)
- DIAGMEX, S.A. DE C.V.
Access comprehensive regulatory information for LIPASA (LIPASE) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1370R2020 SSA and manufactured by DIAGMEX, S.A. DE C.V.. The device was registered on October 08, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.